What is the global market size of Fetal Bovine Serum Market?

Global Fetal Bovine Serum Market size was valued at USD 1.38 Billion in 2021 and is poised to grow from USD 1.57 Billion in 2022 to USD 4.52 Billion by 2030, by rising at a CAGR of 14.1% during the forecast period (2023-2030).

What is the key driver of Global Fetal Bovine Serum Market?

The biopharmaceutical industry witnessed significant growth, with a focus on developing innovative therapeutic solutions. FBS, being an essential component in cell culture-based research, found extensive utilization in drug discovery, preclinical testing, and biologics production. The increasing investment in biopharmaceutical R&D activities drove the demand for FBS.

What is the key market trend for Global Fetal Bovine Serum Market?

Shift towards Animal Component-Free Culture Systems: The industry observed a trend towards the development and adoption of animal component-free culture systems. Researchers and manufacturers sought to reduce the reliance on FBS and transition to defined media formulations that do not contain animal-derived components. This trend aimed to address ethical concerns, enhance experimental reproducibility, and simplify regulatory compliance.

Which region accounted for the largest share in Global Fetal Bovine Serum Market?

In 2022, North America emerged as the dominant region in the global fetal bovine serum (FBS) market, capturing a significant share of 38.0%. This growth can be attributed to the increasing government expenditure on research and development (R&D) activities. The United States, in particular, is renowned for having one of the strongest R&D ecosystems globally. Notably, the biotechnology industry in the U.S. witnessed a substantial 94% growth in R&D expenditure from 2016 to 2021, reaching a total of USD 88.6 billion, as reported in a July 2022 news article. Additionally, factors such as the growing focus on developing biopharmaceutical products, the presence of established market players, and robust healthcare infrastructure further contribute to the market's expansion in the region.

Top Fetal Bovine Serum Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Fetal Bovine Serum Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Fetal Bovine Serum industry players.

Fetal Bovine Serum Market Competitive Landscape

The global fetal bovine serum market is highly competitive and characterized by the presence of several key players. These companies strive to gain a competitive edge by focusing on product quality, expanding their product portfolios, and engaging in strategic partnerships and acquisitions. Thermo Fisher Scientific Inc., a leading player in the market, offers a wide range of FBS products under its Gibco brand, emphasizing quality and consistency to meet the diverse needs of researchers. Merck KGaA, another major player, provides a comprehensive portfolio of FBS products, including serum-free alternatives, catering to the growing demand for animal component-free culture systems. GE Healthcare is actively involved in expanding its FBS manufacturing capabilities and product offerings to meet the rising global demand. Tissue Culture Biologicals, Atlanta Biologicals Inc., and HiMedia Laboratories Pvt. Ltd. are prominent players focusing on delivering high-quality FBS products and addressing specific customer requirements. These companies emphasize stringent quality control measures to ensure the reliability and consistency of their FBS offerings.

Fetal Bovine Serum Market Top Player’s Company Profiles

Thermo Fisher Scientific Inc. (US)

Merck KGaA (Germany)

GE Healthcare (US)

Tissue Culture Biologicals (US)

HiMedia Laboratories Pvt. Ltd. (India)

Atlanta Biologicals Inc. (US)

Sigma-Aldrich Corporation (US)

Rocky Mountain Biologicals (US)

PAN-Biotech GmbH (Germany)

Bovogen Biologicals Pty Ltd. (Australia)

Biowest SAS (France)

Biological Industries Israel Beit Haemek Ltd. (Israel)

Corning Incorporated (US)

Sera Laboratories International Ltd. (UK)

Caisson Laboratories Inc. (US)

Hyclone Laboratories Inc. (US)

Lanzhou Minhai Biotechnology Co., Ltd. (China)

Moregate BioTech (UK)

Gemini Bio-Products (US)

Lampire Biological Laboratories (US)

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Global Fetal Bovine Serum Market size was valued at USD 792.27 Million in 2024 and is poised to grow from USD 846.94 Million in 2025 to USD 1444.35 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026–2033).

Fetal bovine serum providers should focus on solving the ethical concerns surrounding the production of their product to maximize business scope. Targeting countries where investments in cell research are high is expected to offer better returns on investments for fetal bovine serum providers. Fetal bovine serum companies should also try to achieve consistency in different batches of fetal bovine serum to improve consistency of results. 'Thermo Fisher Scientific (USA) ', 'Merck KGaA (Germany) ', 'Danaher Corporation (USA) ', 'Corning Inc. (USA) ', 'Bio-Techne Corporation (USA) ', 'HiMedia Laboratories (India) ', 'PAN-Biotech (Germany) ', 'Bovogen Biologicals Pty Ltd (Australia) ', 'Atlanta Biologicals Inc. (USA) ', 'TCS Biosciences Ltd (UK) ', 'Rocky Mountain Biologicals (RMBIO) (USA) ', 'Biowest (Sera Scandia A/S) (France) ', 'ZenBio, Inc. (USA) ', 'Gemini Bio-Products (USA) ', 'Atlas Biologicals, Inc. (USA) ', 'Moregate Biotech (Australia) ', 'SeraCare Life Sciences (USA) ', 'Access Biologicals (USA) ', 'Biological Industries (Israel) ', 'Wisent Bioproducts (Canada) '

Surging use of monoclonal antibodies, vaccines, and cell therapies for the treatment of various diseases has resulted in high demand for biopharmaceutical research around the world. Fetal bovine serum is a key supplement in cell culture media required for biopharmaceutical production thereby making this a key fetal bovine serum market growth driver.

Use in 3D Cell Culture: Investments in 3D cell culture are increasing rapidly around the world and this is expected to present new opportunities for fetal bovine serum providers in the future. Fetal bovine serum can play a vital role in maintaining stability of complex 3D cell culture systems over the coming years and boost revenue generation potential for market players.

North America is forecasted to account for a high fetal bovine serum market share on a global level. Rising healthcare research and development activity, growing emphasis on improving biopharmaceutical production, and presence of multiple pharmaceutical companies are key factors allowing this region to maintain its dominant stance. The United States is slated to spearhead revenue generation in North America followed by Canada over the coming years. Availability of supportive government funding for medical research and rising investments in stem cell and regenerative medicine research are also slated to create new opportunities for fetal bovine serum providers in this region.

Top Fetal Bovine Serum Companies

Fetal Bovine Serum Market Competitive Landscape

FAQs

What is the global market size of Fetal Bovine Serum Market?

Who are the key vendors in the Fetal Bovine Serum Market?

What is the key driver of Fetal Bovine Serum Market?

What is the key market trend for Fetal Bovine Serum Market?

Which region accounted for the largest share in Fetal Bovine Serum Market?

Request Free Customization